Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 58 Breast Neoplasms 54 Lymphoma 52 Multiple Myeloma 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 48 Leukemia 48 Lymphoma, Non-Hodgkin 46 Melanoma 43 Lymphoma, Large B-Cell, Diffuse 41 Leukemia, Lymphocytic, Chronic, B-Cell 40 Myelodysplastic Syndromes 39 Lymphoma, Follicular 29 Burkitt Lymphoma 25 Hodgkin Disease 24 Neoplasm Metastasis 22 Recurrence 21 Neoplasms 21 Lymphoma, Mantle-Cell 20 Lymphoma, B-Cell, Marginal Zone 18 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18 Ovarian Neoplasms 17 Carcinoma, Non-Small-Cell Lung 17 Primary Myelofibrosis 14 Neoplasms, Plasma Cell 14 Myeloproliferative Disorders 14 Lymphoma, B-Cell 14 Hematologic Neoplasms 14 Leukemia, Myelomonocytic, Chronic 13 Carcinoma, Renal Cell 13 Triple Negative Breast Neoplasms 12

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Cell- and Tissue-Based Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Childhood Solid Tumor × Cyclophosphamide × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡